Scilex Holding Company reposted this
Thanks Nasdaq for inviting the Scilex team and hosting the celebration of the Gloperba launch, we really appreciate this honor. This FDA approval and launch of Gloperba marks the introduction of an innovative gout treatment, allowing the potential for healthcare professionals to prescribe, and patients to finally have access to the first non-opioid oral liquid medicine with precision dosing for the prophylactic treatment of painful gout flares in high-risk patients.
💪 Scilex Holding Company is re-engineering pain management. 🔬 Headquartered in Palo Alto, CA, $SCLX is an innovative pharmaceutical company focused on non-opioid pain management products. 🎉 Today we’re celebrating the launch of Gloperba®, the first and only liquid oral version of anti-gout medicine. Congratulations! #NasdaqListed